Tips of the trade: How to interpret clinical trial results like a pro

Tuesday, Sept. 25 at 1:30 p.m. ET

Subscribe to STAT Plus for $18/month for three months to access this subscriber-only webinar.

Clinical trial data can be remarkably (and unnecessarily) difficult to read. Companies spin, short-sellers hawk, and everyone else is left swimming through the muck.

Subscribe to STAT Plus to join STAT national biotech columnist Adam Feuerstein and STAT senior science writer Sharon Begley for a subscriber-only webinar on what to look for — and what not to fall for — when trying to make sense of the data.